Literature DB >> 11279261

Neurotrophic actions of novel compounds designed from cyclopentenone prostaglandins.

T Satoh1, K Furuta, K Tomokiyo, S Namura, D Nakatsuka, Y Sugie, Y Ishikawa, H Hatanaka, M Suzuki, Y Watanabe.   

Abstract

Previously we found that some cyclopentenone prostaglandin derivatives promoted neurite outgrowth from PC12 cells and dorsal root ganglia explants in the presence of nerve growth factor; and so we referred to them as neurite outgrowth-promoting prostaglandins (NEPPs). In this study, NEPPs protected HT22 cells against oxidative glutamate toxicity. NEPP6, one of the most effective promoters of neurite outgrowth in PC12 cells, protected the cells most potently among NEPPs 1--10. Several derivatives, NEPPs 11--19, were newly synthesized based on the chemical structure of NEPP6. NEPP11 had a more potent neuroprotective effect than NEPP6. NEPP11 also prevented the death of cortical neurons induced by various stimuli and reduced ischemic brain damage in mice. Biotinylated compounds of NEPPs were synthesized to investigate their cellular accumulation. NEPP6-biotin protected the cells and emitted potent signals from the cells. In contrast, biotinylated non-neuroprotective derivatives emitted much weaker signals. These results suggest that NEPPs are novel types of neurotrophic compounds characterized by their dual biological activities of promoting neurite outgrowth and preventing neuronal death and that their accumulation in the cells is closely associated with their neuroprotective actions.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11279261     DOI: 10.1046/j.1471-4159.2001.t01-1-00229.x

Source DB:  PubMed          Journal:  J Neurochem        ISSN: 0022-3042            Impact factor:   5.372


  6 in total

1.  Dual neuroprotective pathways of a pro-electrophilic compound via HSF-1-activated heat-shock proteins and Nrf2-activated phase 2 antioxidant response enzymes.

Authors:  Takumi Satoh; Tayebeh Rezaie; Masaaki Seki; Carmen R Sunico; Takahito Tabuchi; Tomomi Kitagawa; Mika Yanagitai; Mutsumi Senzaki; Chihiro Kosegawa; Hideharu Taira; Scott R McKercher; Jennifer K Hoffman; Gregory P Roth; Stuart A Lipton
Journal:  J Neurochem       Date:  2011-09-21       Impact factor: 5.372

2.  Activation of the Keap1/Nrf2 pathway for neuroprotection by electrophilic [correction of electrophillic] phase II inducers.

Authors:  T Satoh; S-i Okamoto; J Cui; Y Watanabe; K Furuta; M Suzuki; K Tohyama; S A Lipton
Journal:  Proc Natl Acad Sci U S A       Date:  2006-01-09       Impact factor: 11.205

3.  Carnosic acid, a catechol-type electrophilic compound, protects neurons both in vitro and in vivo through activation of the Keap1/Nrf2 pathway via S-alkylation of targeted cysteines on Keap1.

Authors:  Takumi Satoh; Kunio Kosaka; Ken Itoh; Akira Kobayashi; Masayuki Yamamoto; Yosuke Shimojo; Chieko Kitajima; Jiankun Cui; Joshua Kamins; Shu-ichi Okamoto; Masanori Izumi; Takuji Shirasawa; Stuart A Lipton
Journal:  J Neurochem       Date:  2007-11-06       Impact factor: 5.372

4.  Activation of the antioxidant response element by specific oxidized metabolites of linoleic acid.

Authors:  Rui Wang; Jonathan T Kern; Theodore L Goodfriend; Dennis L Ball; Hendrik Luesch
Journal:  Prostaglandins Leukot Essent Fatty Acids       Date:  2009-05-29       Impact factor: 4.006

Review 5.  Nrf2/ARE-mediated antioxidant actions of pro-electrophilic drugs.

Authors:  Takumi Satoh; Scott R McKercher; Stuart A Lipton
Journal:  Free Radic Biol Med       Date:  2013-07-25       Impact factor: 7.376

Review 6.  Redox regulation of antioxidants, autophagy, and the response to stress: implications for electrophile therapeutics.

Authors:  Anna-Liisa Levonen; Bradford G Hill; Emilia Kansanen; Jianhua Zhang; Victor M Darley-Usmar
Journal:  Free Radic Biol Med       Date:  2014-03-26       Impact factor: 7.376

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.